LivaNova announced its board of directors named Vladimir Makatsaria as the company’s CEO and a member of the board of directors, effective March 1. Makatsaria most recently served as company group chairman at Johnson & Johnson MedTech, leading its global Ethicon surgery business. Makatsaria will succeed Kozy, who has served as interim CEO since April 2023. Kozy will continue in his role as LivaNova board chair.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LIVN:
